Heptavac P Plus

Kraj: Wielka Brytania

Język: angielski

Źródło: VMD (Veterinary Medicines Directorate)

Składnik aktywny:

Clostridium chauvoei, Clostridium novyi, Clostridium perfringens, Clostridium septicum, Clostridium tetani, Mannheimia haemolytica, Pasteurella trehalosi

Dostępny od:

MSD Animal Health UK Limited

Kod ATC:

QI04AB05

INN (International Nazwa):

Clostridium chauvoei, Clostridium novyi, Clostridium perfringens, Clostridium septicum, Clostridium tetani, Mannheimia haemolytica, Pasteurella trehalosi

Forma farmaceutyczna:

Suspension for injection

Typ recepty:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupa terapeutyczna:

Sheep

Dziedzina terapeutyczna:

Inactivated Bacterial Vaccine

Status autoryzacji:

Authorized

Data autoryzacji:

1997-06-11

Charakterystyka produktu

Revised: May 2024
AN: 00961/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Heptavac P Plus suspension for injection for sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml of vaccine contains:
ACTIVE SUBSTANCES:
_Clostridium perfringens_ beta toxoid
≥ 10 IU
*
_Clostridium perfringens_ epsilon toxoid
≥ 5 IU
*
_Clostridium septicum_ toxoid
≥ 2.5 IU
*
_Clostridium tetani_ toxoid
≥ 2.5 IU
*
_Clostridium novyi_ toxoid
≥ 3.5 IU
*
Inactivated_ Clostridium chauvoei_
≥ 0.5 guinea pig PD
90
#
Inactivated _Mannheimia haemolytica_ A1, A2, A6, A7, A9
5x10
8
cells per strain
Inactivated _Pasteurella_ _trehalosi_ T3, T4, T10, T15
5x10
8
cells per strain
*
International Units of antitoxin, conform Ph.Eur.
#
Protective Dose 90%, conform Ph.Eur.
ADJUVANT:
Aluminium hydroxide gel
400 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF
EXCIPIENTS AND OTHER CONSTITUENTS
QUANTITATIVE COMPOSITION IF THAT
INFORMATION IS ESSENTIAL FOR PROPER
ADMINISTRATION OF THE VETERINARY
MEDICINAL PRODUCt
Thiomersal
0.067-0.15 mg
Tris
Maleic acid
Sodium chloride
Formaldehyde
Water
Opaque suspension.
Revised: May 2024
AN: 00961/2023
Page 2 of 6
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Sheep.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the active immunisation of sheep as an aid in the control of lamb
dysentery,
pulpy kidney, struck, tetanus, braxy, blackleg, black disease,
clostridial metritis
caused by _Clostridium perfringens_ types B, C and D, _Cl.septicum_,
_Cl.novyi_,
_Cl.chauvoei_ and _Cl.tetani_. The vaccine may be used as an aid in
the control of
pneumonic pasteurellosis in sheep of all ages from a minimum age of 3
weeks and in
the control of systemic pasteurellosis in weaned fattening and
breeding sheep.
The vaccine may be used in pregnant ewes as an aid in the control of
lamb
dysentery, pulpy kidney, tetanus and pasteurellosis in their lambs
provided that the
lambs receive sufficient immune colostrum during the first 1-2 days of
life.
Onset of immunity: As with most inactivated